John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 1,641 shares at $17.53 ($29K) on 2023-09-05, disclosed to the SEC on 2023-09-06.
Scheduled sale ($29k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.76 | 734 | $13K | 44.9% |
| 2 | $17.76 | 507 | $9K | 31.0% |
| 3 | $17.53 | 400 | $7K | 24.1% |
| Total | $17.70 avg | 1,641 | $29K | 100% |
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |